For example, in AD, amyloid precursor protein (APP) and β-amyloid are increased in both neurons and osteoblasts, where they impair neuronal and osteoblast function and proliferation, and these molecules have also been shown in transgenic mice to promote the activity of osteoclasts leading to greater bone resorption [83]. This evidence concerns the gene APP and Alzheimer disease.